Biogen’s Alzheimer’s Drug Impresses in Early Trial

March 20, 2015 4:44 PM

16 10

Biogen’s Alzheimer’s Drug Impresses in Early Trial

A Biogen Idec Inc. drug that targets plaque buildup in the brain slowed cognitive decline in patients with early and mild forms of Alzheimer’s disease in a small, early-stage study, lifting the company’s stock to all-time highs and adding to the debate on how to treat the debilitating disease.

The treatment still requires larger and longer drug trials, and may not be suitable for all patients. However, the results excited observers because of the consistency of the drug’s effects, which increased with higher doses. Analysts also were encouraged by brain imaging scans showing plaque reduct...

Also read: Mohamed Salah fit to play barring last fitness test, Egypt say

Read more

To category page